In these experiments, we found that anti-PD1 therapy could suppress the growth of P3CA-AR-V7 tumor growth compared to controls (Figure 5c), but that long-term survival was only altered in groups receiving combination Ad-AR-V7 and anti-PD1 treatment (Figure 5c,d). The gene discussed is AR; the disease is neoplasm.